Baxter International Inc. (BVMF:B1AX34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 43.21B -57.9% |
| Revenue (ttm) | 61.93B +5.7% |
| Net Income | -5.27B |
| EPS | -10.28 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 8.39 |
| Dividend | 0.66 (1.46%) |
| Ex-Dividend Date | Feb 26, 2026 |
| Volume | 100 |
| Average Volume | 160 |
| Open | 45.00 |
| Previous Close | 43.36 |
| Day's Range | 45.00 - 45.00 |
| 52-Week Range | 43.36 - 95.58 |
| Beta | 0.55 |
| RSI | 40.03 |
| Earnings Date | Apr 30, 2026 |
About Baxter International
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies;... [Read more]
Financial Performance
In 2025, Baxter International's revenue was $11.24 billion, an increase of 5.72% compared to the previous year's $10.64 billion. Losses were -$957.00 million, 47.5% more than in 2024.
Financial numbers in USD Financial StatementsNews
Baxter to Host Annual Meeting of Stockholders in Virtual Format
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, ...
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot
Largest Single Investment from a Corporate Foundation Aims to Strengthen Healthcare Resilience by Advancing Therapy Animal Visits in U.S. Healthcare Settings BELLEVUE, Wash. and DEERFIELD, Ill.
EU regulator warns of shortage in Baxter's cancer treatment until early 2027
The European Union's medicines regulator said on Tuesday it expects Baxter International's cancer drugs containing ifosfamide will remain in shortage in the bloc well into the first quarter of next ...
Baxter Announces CFO Transition
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Joel Grade....
Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Baxter International Inc. (BAX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Sticking With Baxter At The Lows
Baxter International faces deep investor skepticism after disappointing guidance and management's decision to delay its Investor Day. Recent leadership changes and a flattened organizational structure...
Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Baxter International Inc. (BAX) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
Biggest S&P 500 Winners Last 5, 10, 20 Years
The S&P 500's annualized total return over the last five years has been roughly 13.5%, but the average stock currently in the index has seen an annualized total return about 2.6 percentage points less...
Artisan Value Income Fund Q4 2025 Portfolio Activity
Our largest new purchase was Houston-headquartered Prosperity BancShares, the fifth-largest bank in Texas. Another notable purchase was Union Pacific, the largest freight railroad in the US. Besides o...
Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade)
Baxter International faces a fundamental downturn after weak Q4 results and a dismal FY 2026 guide, prompting a hold rating downgrade. BAX trades at a very cheap valuation, but persistent margin compr...
Baxter International Inc. (BAX) Q4 2025 Earnings Call Transcript
Baxter International Inc. (BAX) Q4 2025 Earnings Call Transcript
Baxter Shares Tank As 2026 Profit Guidance Falls Below Expectations
Baxter reported a fourth-quarter adjusted EPS of 44 cents, below the management guidance of 52-57 cents and the Wall Street estimate of 54 cents. The decrease was driven primarily by an unfavorable pr...
Baxter forecast 2026 profit below estimates
Medical products maker Baxter forecast annual profit below Wall Street estimates on Thursday, due to persistent impact from hurricane-related disruptions at a key manufacturing unit.
Baxter Reports Fourth-Quarter 2025 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025. “While we delivered sales growth across all segm...
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its fourth-quarter 2025 financial results on Thursday, ...
The Bottom Fishing Club - Baxter: Defensive Pick, Restructuring And Paying Down Debt
Baxter International offers a compelling defensive play, trading at historically low valuations after significant deleveraging and operational headwinds. BAX's forward cash earnings multiple is around...
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings
DEERFIELD, Ill.--(BUSINESS WIRE)--BAXTER INTRODUCES THE DYNAMO SERIES, A NEW SMART STRETCHER TO HELP ADDRESS COMMON CHALLENGES IN HOSPITAL SETTINGS.
Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Baxter International Inc. (BAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges
CHARLESTON, S.C.--(BUSINESS WIRE)--MUSC Health and Baxter International Inc. (NYSE:BAX), a global medtech leader, are entering into a multi-year strategic partnership that aims to enhance the high-qua...
Baxter to Present at J.P. Morgan 2026 Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026. Andrew Hider, B...
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Baxter International and Molina Healthcare on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Baxter International, Inc....
DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference
LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Dr. Walter Jacobson, a Los Angeles-based psychiatrist, author, and first-time filmmaker, scored a major win at this year's American Film Market (AFM) Pit...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...
Scrooge: 5 Stocks That Could Ruin Your Santa Rally
Investors are hoping for a Santa Rally — the seasonal year-end surge that has historically delivered positive returns. Although macro conditions - including rate cuts and easing inflation - are suppor...